![Brad L. Stewart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brad L. Stewart
Career history of Brad L. Stewart
Former positions of Brad L. Stewart
Companies | Position | Start | End |
---|---|---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Chairman | 13/09/2009 | 17/11/2013 |
President | - | 17/11/2013 | |
Tech Council of Maryland, Inc.
![]() Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Director/Board Member | 18/07/2011 | - |
Training of Brad L. Stewart
University of Florida | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Chairman | 1 |
President | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Health Technology |
Tech Council of Maryland, Inc.
![]() Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
- Stock Market
- Insiders
- Brad L. Stewart
- Experience